Cdkn2a Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST.
Chaney, KE; Perrino, MR; Kershner, LJ; Patel, AV; Wu, J; Choi, K; Rizvi, TA; Dombi, E; Szabo, S; Largaespada, DA; et al.
Cancer Research.
2020;
80:4720-4730.
The Role of RUNX1 in NF1-Related Tumors and Blood Disorders.
Na, Y; Huang, G; Wu, J.
Molecules and Cells.
2020;
43:153-159.
The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies.
Yokota, A; Huo, L; Lan, F; Wu, J; Huang, G.
Molecules and Cells.
2020;
43:145-152.
NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation.
Yu, Y; Choi, K; Wu, J; Andreassen, PR; Dexheimer, PJ; Keddache, M; Brems, H; Spinner, RJ; Cancelas, JA; Martin, LJ; et al.
Acta Neuropathologica.
2020;
139:157-174.
The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin.
Rice, FL; Houk, G; Wymer, JP; Gosline, SJ C; Guinney, J; Wu, J; Ratner, N; Jankowski, MP; La Rosa, S; Dockum, M; et al.
PLoS ONE.
2019;
14:e0216527-e0216527.
RUNX represses Pmp22 to drive neurofibromagenesis.
Hall, A; Choi, K; Liu, W; Rose, J; Zhao, C; Yu, Y; Na, Y; Cai, Y; Coover, RA; Lin, Y; et al.
Science Advances.
2019;
5:eaau8389-eaau8389.
STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.
Fletcher, JS; Springer, MG; Choi, K; Jousma, E; Rizvi, TA; Dombi, E; Kim, M; Wu, J; Ratner, N.
Oncogene: Including Oncogene Reviews.
2019;
38:2876-2884.
Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice.
Fletcher, JS; Wu, J; Jessen, WJ; Pundavela, J; Miller, JA; Dombi, E; Kim, M; Rizvi, TA; Chetal, K; Salomonis, N; et al.
JCI insight.
2019;
4.
Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.
Wu, LM N; Deng, Y; Wang, J; Zhao, C; Wang, J; Rao, R; Xu, L; Zhou, W; Choi, K; Rizvi, TA; et al.
Cancer Cell.
2018;
33:292-308.e7.
A Collaborative Model for Accelerating the Discovery and Translation of Cancer Therapies.
Maertens, O; McCurrach, ME; Braun, BS; De Raedt, T; Epstein, I; Huang, TQ; Lauchle, JO; Lee, H; Wu, J; Cripe, TP; et al.
Cancer Research.
2017;
77:5706-5711.